^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

DICER1 (Dicer 1 Ribonuclease III)

i
Other names: DICER1, Dicer 1 Ribonuclease III, HERNA, Dicer 1 Double-Stranded RNA-Specific Endoribonuclease, Dicer 1 Ribonuclease Type III, Endoribonuclease Dicer, K12H4.8-LIKE, Helicase MOI, KIAA0928, Dicer, Dicer1 Dcr-1 Homolog (Drosophila), Helicase With RNAse Motif, Helicase With RNase Motif, Multinodular Goitre 1, Dicer1 Dcr-1 Homolog, Dicer1e, DICER1, RMSE2, DICER, DCR1, GLOW, MNG1
7d
Genomic modifiers of malignant and neurodevelopmental phenotypes in individuals with PTEN hamartoma tumor syndrome. (PubMed, NPJ Genom Med)
Genome-wide analyses identified candidate modifier loci functionally linked to PTEN, including in ZNF713, TPTE2P1, and PDPK1. These findings demonstrate that PHTS phenotypes are shaped by complex gene-gene interactions beyond PTEN alone, informing mechanisms underlying the cancer-NDD dichotomy and advancing precision risk stratification.
Journal • BRCA Biomarker
|
BRCA2 (Breast cancer 2, early onset) • PTEN (Phosphatase and tensin homolog) • DICER1 (Dicer 1 Ribonuclease III) • MITF (Melanocyte Inducing Transcription Factor) • DHCR7 (7-Dehydrocholesterol Reductase) • PDPK1 (3-Phosphoinositide dependent protein kinase 1)
9d
Evaluation of DICER1 Immunohistochemistry as a Potential Surrogate for Mutation Status in Ovarian Sex Cord-Stromal Tumors. (PubMed, Mod Pathol)
However, in SCT the DICER1 expression is common, but unrelated to DICER1 mutation. This suggests that alternative mechanisms, potentially involving androgen-related pathways, may contribute to DICER1 expression in these tumors.
Journal
|
DICER1 (Dicer 1 Ribonuclease III)
12d
DICER1 Syndrome With Embryonal Rhabdomyosarcoma of the Uterine Cervix and Retroperitoneal Metastasis: A Case Report and Literature Review. (PubMed, Case Rep Obstet Gynecol)
Multiple gene mutations, in addition to DICER1 gene mutation, may influence the behavior and prognosis of DICER1 syndrome. We detail the necessity of instituting personalized, multidisciplinary monitoring plans, including regular clinical evaluations and targeted imaging of high-risk organs, to enable early detection and intervention.
Journal
|
TP53 (Tumor protein P53) • NF1 (Neurofibromin 1) • DICER1 (Dicer 1 Ribonuclease III)
|
TP53 mutation
13d
Extracranial teratoid medulloepithelioma: A pelvic observation with genetic and epigenetic findings. (PubMed, Virchows Arch)
Herein, we report a pediatric case of a presacral tumor classified as a teratoid medulloepithelioma with genetic and epigenetic charaterizations. Using DNA-methylation profiling analysis, the tumor was classified between ETMR, non C19MC-altered, and intra-ocular medulloepithelioma, arguing for a potential distinct cell origin, not represented in the current epigenetic classifiers.
Journal
|
DICER1 (Dicer 1 Ribonuclease III)
16d
DICER1-Related Primitive Polyphenotypic Neoplasm: A Report of 15 Cases of an Underrecognized Tumor of the Gynecologic Tract and Peritoneum. (PubMed, Am J Surg Pathol)
DICER1-related primitive polyphenotypic neoplasms present significant diagnostic difficulty due to their varied appearances and lack of consistent nomenclature in the rare reports to date. Recognition of the morphologic features of these unusual neoplasms should prompt confirmatory DICER1 testing and consideration of germline evaluation, particularly in young patients.
Journal
|
GPC3 (Glypican 3) • DICER1 (Dicer 1 Ribonuclease III) • SALL4 (Spalt Like Transcription Factor 4)
19d
Structural insights into disease-associated mutations in the microRNA processing machinery. (PubMed, Exp Mol Med)
Such mutations disrupt RNA cleavage fidelity, destabilize domain architecture or hinder small RNA loading, leading to cancers and developmental disorders, including Wilms tumor, DICER1 syndrome, myelodysplastic syndromes and Lessel-Kreienkamp syndrome. This Review highlights the structural basis of these pathogenic mutations and discusses how emerging insights from structural biology are shaping our understanding of RNA interference-related disease mechanisms and guiding potential therapeutic strategies.
Review • Journal
|
DICER1 (Dicer 1 Ribonuclease III)
26d
Microwave ablation treatment for follicular nodular disease in DICER1 syndrome: a case report. (PubMed, Postgrad Med)
She was successfully treated with ultrasound-guided microwave ablation, and we describe her clinical course in detail. This case underscores the importance of considering DICER1 syndrome in young patients with FND and illustrates that microwave ablation can be a safe and effective therapeutic option.
Journal
|
DICER1 (Dicer 1 Ribonuclease III)
27d
Canonical microRNA loss drives tumor development implicating therapeutic efficacy of enoxacin in angiosarcoma. (PubMed, RNA)
ENX increases the abundance of tumor-suppressive miRNAs and downregulates oncogenic pathways, including pathways related to cell cycle progression, angiogenesis, and cell migration. These results establish the essential role of miRNA biogenesis in suppressing AS and reveal a pharmacologically targetable vulnerability via ENX-mediated enhancement of miRNA expression in tumors.
Journal
|
DICER1 (Dicer 1 Ribonuclease III)
27d
A Case of Ovarian Primary Solid Pseudopapillary Neoplasm With Multiple Organ Metastases. (PubMed, Int J Gynecol Pathol)
This case underscores the diagnostic importance of recognizing ovarian SPN and its potential for aggressive behavior. Awareness of its morphologic, immunophenotypic, and molecular features is essential for distinction from other ovarian tumors.
Journal
|
CTNNB1 (Catenin (cadherin-associated protein), beta 1) • CDH1 (Cadherin 1) • DICER1 (Dicer 1 Ribonuclease III) • FOXL2 (Forkhead Box L2)
30d
A case of ovarian Sertoli-Leydig cell tumor with high grade transformation harbouring DICER1 and TP53 mutations. (PubMed, Virchows Arch)
In addition, a pathogenic TP53 mutation was detected exclusively in the high-grade area. This case represents only the second documented ovarian SLCT with confirmed high-grade transformation supported by a concurrent TP53 alteration.
Journal
|
TP53 (Tumor protein P53) • DICER1 (Dicer 1 Ribonuclease III)
|
TP53 mutation
30d
Surgical Management of Congenital Lung Malformations in Children-A Single-Center Analysis of 25 Years of Experience. (PubMed, Clin Respir J)
The study underscores the heterogeneity in age and clinical presentation at the time of CLM diagnosis, highlighting the importance of an individualized and tailored approach to management.
Retrospective data • Journal
|
KRAS (KRAS proto-oncogene GTPase) • DICER1 (Dicer 1 Ribonuclease III)
|
KRAS mutation